Table 2.
Infusion schedule
|
|||
---|---|---|---|
2-week (10–17 days) | 3-week (18–23 days) | 4-week (24–34 days) | |
Number of patients* | 10 | 8 | 9 |
Mean | 5,836.8 | 3,304.8 | 1,715.6 |
SD | 1,178.4 | 1,130.7 | 547.6 |
Median | 5,490.0 | 3,201.0 | 1,599.2 |
Min | 4,528.3 | 1,840.0 | 655.0 |
Max | 8,167.5 | 5,280.0 | 2,423.3 |
Patients contribute one Daclizumab level per infusion interval, with the level being the patient’s mean level within the interval.